Bioactive baculovirus nanohybrids for stent based rapid vascular re-endothelialization

Area of Science:

• Biomaterials Science
• Gene Therapy
• Cardiovascular Research

Background:

• Vascular injury during stenting often leads to neointima formation and artery re-narrowing.
• Efficient local delivery of pro-angiogenic factors is crucial for promoting vascular healing.
• Current stent technologies have limitations in addressing post-stenting complications.

Purpose of the Study:

• To develop and evaluate a novel nanohybridized baculovirus-based stent for localized gene delivery.
• To assess the stent's efficacy in promoting vascular re-endothelialization and reducing neointima formation.
• To investigate the potential of this biotherapeutic stent in improving vascular repair after injury.

Main Methods:

• Development of a nanohybridized baculovirus vector for gene delivery.
• Fabrication of a stent system incorporating the baculovirus vector.
• In vitro assessment of vascular endothelial growth factor (VEGF) expression in transduced cells.
• In vivo studies in a canine femoral artery model to evaluate endothelial recovery and neointima formation.

Main Results:

• The nanohybridized baculovirus stent demonstrated efficient delivery and expression of functional VEGF genes.
• In vitro studies showed rapid and active VEGF expression by stent-transduced vascular cells.
• In vivo studies confirmed site-specific transgene expression in stented arteries.
• Significant reduction in neointima formation and percent stenosis was observed in the treated group compared to controls.

Conclusions:

• The developed baculovirus-based biotherapeutic stent shows significant potential for promoting vascular repair.
• This novel stent effectively delivers pro-angiogenic genes, enhancing endothelial recovery.
• The findings suggest the stent can ameliorate damaged vascular biology and prevent artery re-narrowing.